Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · IEX Real-Time Price · USD
4.120
-0.140 (-3.29%)
Jul 22, 2024, 10:06 AM EDT - Market open

Jaguar Health Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2014
Cash & Equivalents
11.676.475.4717.058.093.88
Upgrade
Cash & Cash Equivalents
11.676.475.4717.058.093.88
Upgrade
Cash Growth
-18.77%18.28%-67.93%110.77%108.34%51.20%
Upgrade
Receivables
1.712.182.472.144.561.69
Upgrade
Inventory
9.029.197.024.92.782.13
Upgrade
Other Current Assets
11.3110.127.364.342.361.82
Upgrade
Total Current Assets
33.7127.9622.3228.4317.799.52
Upgrade
Property, Plant & Equipment
1.771.671.71.730.681.26
Upgrade
Goodwill and Intangibles
19.6320.1222.4422.6524.3426.02
Upgrade
Other Long-Term Assets
0.281.0110.450.04-0.4
Upgrade
Total Long-Term Assets
21.6822.825.1324.8325.0526.89
Upgrade
Total Assets
55.3950.7647.4553.2742.8436.41
Upgrade
Accounts Payable
3.324.975.814.934.765.35
Upgrade
Deferred Revenue
0.8500000
Upgrade
Current Debt
10.865.2216.373.423.797.12
Upgrade
Other Current Liabilities
2.783.88.177.124.672.93
Upgrade
Total Current Liabilities
17.8113.9930.3415.4713.2215.39
Upgrade
Long-Term Debt
22.5931.8818.4725.9412.420.45
Upgrade
Other Long-Term Liabilities
0.6800000
Upgrade
Total Long-Term Liabilities
23.2731.8818.4725.9412.420.45
Upgrade
Total Liabilities
41.0945.8748.8141.4125.6415.84
Upgrade
Total Debt
33.4637.0934.8429.3716.217.57
Upgrade
Debt Growth
-2.45%6.48%18.63%81.15%114.28%-52.97%
Upgrade
Retained Earnings
-317.22-308.25-266.95-219.49-166.9-133.09
Upgrade
Comprehensive Income
-0.46-0.65-0.68000
Upgrade
Shareholders' Equity
124.96-0.6611.6117.210.67
Upgrade
Net Cash / Debt
-21.78-30.63-29.37-12.31-8.12-3.68
Upgrade
Net Cash Per Share
-8.23-79.65-1343.43-1239.33-2837.18-10005.43
Upgrade
Working Capital
15.913.98-8.0212.964.57-5.87
Upgrade
Book Value Per Share
4.5312.90-30.061168.596009.7629019.28
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).